Summary

Eligibility
for people ages 18 years and up (full criteria)
Location
at UCSD
Dates
study started
completion around

Description

Summary

The primary aim of this implementation-effectiveness trial is to examine the effectiveness of Mindfulness-Oriented Recovery Enhancement (MORE) and patient-centered chronic pain management visits in primary care as interventions to reduce chronic pain, improve quality of life, and reduce opioid-related harms among chronic pain patients on long-term opioid therapy.

Keywords

Chronic Pain, Prescription Opioid Misuse, Substance-Related Disorders, Pain, Narcotic-Related Disorders, Chemically-Induced Disorders, Mental Disorders, Opioid-Related Disorders, Neurologic Manifestations, Mindfulness Oriented Recovery Enhancement, Patient-Centered Chronic Pain Management Visits

Eligibility

You can join if…

Open to people ages 18 years and up

  • Age 18 +
  • Current chronic pain diagnosis (pain for ≥3 months) determined by physician assessment
  • Current use of opioids for ≥3 months
  • Score >=3 on the Pain Enjoyment General Activity scale
  • Score >=9 on the Current Opioid Misuse Measure OR lifetime psychiatric or substance use disorder diagnosis OR benzodiazepine use OR history of overdose OR physician determination that risks of opioid use may outweigh the benefits of opioid use

You CAN'T join if...

  • Chronic pain due to a cancer diagnosis
  • Active suicidal intent, schizophrenia, psychotic disorder
  • Prior experience with Mindfulness-Based Stress Reduction, Mindfulness-Based Cognitive Therapy, Mindfulness-Based Relapse Prevention, or Mindfulness-Oriented Recovery Enhancement

Locations

  • UCSD Health accepting new patients
    La Jolla California 92037 United States
  • University of Utah Primary Care Clinics not yet accepting patients
    Salt Lake City Utah 84112 United States
  • Rutgers University Primary Care Clinics accepting new patients
    New Brunswick New Jersey 08901 United States

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of Utah
ID
NCT06387290
Study Type
Interventional
Participants
Expecting 300 study participants
Last Updated